Why this matters: Compounding means a pharmacy takes an active ingredient and mixes or combines it into a custommade medication for an individual patient
Therefore, robust LC-MS characterization is essential to demonstrate biosimilar equivalence
Collected variables The following data were collected at baseline, and at the 6- and 12-month follow-up visits: anthropometric parameters, namely, weight, body mass index (BMI), waist circumference, and blood pressure
6.1 Expression of GLP-1 and GIP Receptors in the Brain GLP-1 receptors are expressed on neurons in most areas of the brain, including the cortex, hippocampus, and the striatum [105,106,107,108,109,110]
The subjects treated with tirzepatide lost 21.4% of their body weight, on average, over 12 months, equating to 49.4lb (22.4kg)
A study utilizing a national database found that individuals treated with GLP-1 receptor agonists had a significantly lower risk of developing glaucoma compared to those who were not on these medications